BioCryst Pharmaceuticals
BCRX
#4608
Rank
S$2.19 B
Marketcap
$10.62
Share price
2.39%
Change (1 day)
2.03%
Change (1 year)

EPS for BioCryst Pharmaceuticals (BCRX)

EPS in 2023 (TTM): -$1.68

According to BioCryst Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.63. In 2022 the company made an earnings per share (EPS) of -$1.73 a decrease over its 2021 EPS that were of -$1.34.

EPS history for BioCryst Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.68-2.9%
2022-$1.7329.13%
2021-$1.34-4.63%
2020-$1.4110.2%
2019-$1.280%
2018-$1.2825.64%
2017-$1.024%
2016-$0.9827.12%
2015-$0.77-13.24%
2014-$0.8923.64%
2013-$0.72-30.38%
2012-$1.03-37.3%
2011-$1.6465.79%
2010-$0.99117.14%
2009-$0.46-46.15%
2008-$0.85-26.97%
2007-$1.16-40.67%
2006-$1.9548.51%
2005-$1.321%
2004-$1.3038.89%
2003-$0.94-25%
2002-$1.25231.03%
2001-$0.38-56.72%
2000-$0.8791.43%
1999-$0.462.94%
1998-$0.44-55.84%
1997-$1.0011.59%
1996-$0.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.72-267.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$10.20 526.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.77-52.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.37 475.20%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.72-451.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.13 92.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.56-380.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$15.73 866.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.00-38.40%๐Ÿ‡บ๐Ÿ‡ธ USA